Boshuizen, Julia http://orcid.org/0000-0002-8135-0525
Koopman, Louise A
Krijgsman, Oscar
Shahrabi, Aida
van den Heuvel, Elke Gresnigt–
Ligtenberg, Maarten A
Vredevoogd, David W http://orcid.org/0000-0001-6718-1422
Kemper, Kristel
Kuilman, Thomas http://orcid.org/0000-0001-6724-6767
Song, Ji-Ying
Pencheva, Nora
Mortensen, Jens Thing
Foppen, Marnix Geukes
Rozeman, Elisa A
Blank, Christian U
Janmaat, Maarten L
Satijn, David
Breij, Esther C W
Peeper, Daniel S http://orcid.org/0000-0003-1293-3177
Parren, Paul W H I http://orcid.org/0000-0002-4365-3859
Article History
Received: 28 March 2017
Accepted: 15 December 2017
First Online: 15 January 2018
Competing interests
: L.K., E.B., E.G.-v.d.H., N.P., M.J. and D.S. are full-time Genmab employees and have warrants and/or stock. P.P. is a Genmab shareholder. C.U.B. receives grants and/or research support from Novartis and BMS, and has received honoraria or consultation fees for MSD, BMS, Roche, Novartis, GSK, Pfizer and Lilly, and is a stock shareholder of Verastem.